 free light chains urine patients multiple sclerosis free kappa kappa lambda light chains coded urine specimens subjects definite multiple sclerosis MS neurologic diseases OND age-matched normal controls Urine MS patients significant increases free chains groups overlap MS patients OND patients ratio kappa/creatinine relapsing-remitting MS group patients stable MS OND normal controls free chains independent urinary albumin levels Serial studies urinary free kappa/creatinine ratios periods clinical worsening MS patients clinical recovery measurement free chains urine intervals MS patients useful marker disease activity